ezDiaTECH

Cheonan, South Korea Founded: 2016 • Age: 10 yrs
In-vitro diagnostic assays for multiple diseases are provided.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 11 Brand Intelligence

About ezDiaTECH

ezDiaTECH is a company based in Cheonan (South Korea) founded in 2016. ezDiaTECH offers products and services including VEUS and VEUPLEX™ TBI assay. ezDiaTECH operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.

  • Headquarter Cheonan, South Korea
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name 주식회사 이지다이아텍
  • Jurisdiction Na, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ezDiaTECH

ezDiaTECH offers a comprehensive portfolio of products and services, including VEUS and VEUPLEX™ TBI assay.

Primary

Automated platform for rapid and accurate disease detection using AI.

Kit for quick traumatic brain injury diagnosis via biomarkers.

Funding Insights of ezDiaTECH

Investments & Acquisitions by ezDiaTECH

Investments

Financial Statements - ezDiaTECH

Ezdiatech Comparisons

+
Add Comparison
Available on Premium

Competitors of ezDiaTECH

ezDiaTECH operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of diagnostic solutions for systemic infections
domain founded_year HQ Location
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
domain founded_year HQ Location
Provider of machine learning based diagnostic solutions for infectious diseases
domain founded_year HQ Location
Portable PCR diagnostics for infectious diseases are developed.
domain founded_year HQ Location
Instruments and test panels for multiplexed molecular diagnostics are provided.
domain founded_year HQ Location
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.

Latest news on Ezdiatech

Frequently Asked Questions about ezDiaTECH

ezDiaTECH was founded in 2016.

ezDiaTECH is headquartered in Cheonan, South Korea. It is registered at Cheonan, Chungcheongnam-do, South Korea.

ezDiaTECH was founded in 2016 and is based in Cheonan, South Korea. In-vitro diagnostic assays targeting multiple diseases are developed and supplied by the company within the healthcare sector. Operations focus on medical diagnostics, with services extending to assay production and distribution for clinical applications. The firms activities are centered in the biotechnology field, supporting disease detection through reliable testing solutions across various regions.

ezDiaTECH's top competitors include Visby Medical, Inflammatix and MeMed.

ezDiaTECH offers VEUS and VEUPLEX™ TBI assay.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available